Summary: Dr. Teshamae Monteith discusses takeaways from the first year of use with CGRP monoclonal antibodies for migraine prevention.
Summary: Dr. Teshamae Monteith discusses takeaways from the first year of use with CGRP monoclonal antibodies for migraine prevention.